lorazepam has been researched along with Ache in 28 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-seven per cent of surgical patients receiving undiluted diazepam experienced pain on injection while 6-16%, depending on the dose, manifested evidence of clinical thrombophlebitis." | 9.04 | Pain and clinical thrombophlebitis following intravenous diazepam and lorazepam. ( Conner, JT; Graham, CW; Pagano, RR, 1978) |
| "Pain was rated using a 10-cm linear visual analog scale (VAS)." | 6.73 | A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy. ( Ahn, JY; Bang, SM; Cho, EK; Lee, JH; Nam, E; Park, SH; Shin, DB, 2008) |
| "To compare pain and anxiety levels between two prophylactic treatment regimens, a combination of sublingual tramadol Hcl with oral lorazepam and oral diazepam only." | 5.15 | Prophylactic analgesia before percutaneous liver biopsy: a clinical comparative study. ( Baruch, Y; Eisenberg, E; Kramskay, R; Tansky, A; Veitsman, E, 2011) |
| ") lorazepam and hydromorphone reduces pain and anxiety during BMBA." | 5.09 | A randomized, placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma. ( Habermann, TM; Inwards, DJ; Schroeder, G; Wilson, PR; Witzig, TE; Wolanskyj, AP, 2000) |
| "Eighty-seven per cent of surgical patients receiving undiluted diazepam experienced pain on injection while 6-16%, depending on the dose, manifested evidence of clinical thrombophlebitis." | 5.04 | Pain and clinical thrombophlebitis following intravenous diazepam and lorazepam. ( Conner, JT; Graham, CW; Pagano, RR, 1978) |
| " Indications for droperidol included agitation, 68 (86%); nausea/vomiting, 7 (9%); headache, 2 (3%); and other pain, 2 (3%)." | 3.76 | Droperidol use in pediatric emergency department patients. ( Sacchetti, A; Szwak, K, 2010) |
| " The case presentation illustrates the role of pregabalin in successful medical management of this chronic pain disorder, as well as the management of common psychiatric morbidities associated with this condition." | 3.74 | Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. ( Jerome, L, 2007) |
| "Pain was rated using a 10-cm linear visual analog scale (VAS)." | 2.73 | A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy. ( Ahn, JY; Bang, SM; Cho, EK; Lee, JH; Nam, E; Park, SH; Shin, DB, 2008) |
| " A 30-year-old female elite athlete developed lormetazepam addiction after increasing her daily benzodiazepine dosage in an attempt to achieve better sleep and enhanced performances during training." | 1.51 | Benzodiazepine abuse among athletes: Pain relief or just a weapon against insomnia? A clinical case study. ( Lugoboni, F; Zamboni, L; Zandonai, T, 2019) |
| "Lorazepam was given most often because of anxiety and agitation, oxazepam to induce sleep and midazolam in five cases of terminal sedation." | 1.35 | [Indications and use of benzodiazepines in a palliative care unit]. ( Elsner, F; Krumm, N; Radbruch, L; Schroers, O; Stiel, S, 2008) |
| " Demographic data, time in ED, and dosage of each medication given were abstracted." | 1.35 | Inadequate provision of postintubation anxiolysis and analgesia in the ED. ( Bonomo, JB; Butler, AS; Lindsell, CJ; Venkat, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.86) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 12 (42.86) | 29.6817 |
| 2010's | 4 (14.29) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Wiemann, B | 3 |
| Mitchell, J | 3 |
| Sarangarm, P | 3 |
| Miskimins, R | 3 |
| Tripathi, S | 1 |
| Laksana, E | 1 |
| McCrory, MC | 1 |
| Hsu, S | 1 |
| Zhou, AX | 1 |
| Burkiewicz, K | 1 |
| Ledbetter, DR | 1 |
| Aczon, MD | 1 |
| Shah, S | 1 |
| Siegel, L | 1 |
| Fainberg, N | 1 |
| Morrow, KR | 1 |
| Avesar, M | 1 |
| Chandnani, HK | 1 |
| Shah, J | 1 |
| Pringle, C | 1 |
| Winter, MC | 1 |
| Zamboni, L | 1 |
| Lugoboni, F | 1 |
| Zandonai, T | 1 |
| Stiel, S | 1 |
| Krumm, N | 1 |
| Schroers, O | 1 |
| Radbruch, L | 1 |
| Elsner, F | 1 |
| Zeilhofer, HU | 1 |
| Witschi, R | 1 |
| Hösl, K | 1 |
| Talamo, G | 1 |
| Liao, J | 1 |
| Bayerl, MG | 1 |
| Claxton, DF | 1 |
| Zangari, M | 1 |
| Wowchuk, SM | 1 |
| Wilson, EA | 1 |
| Embleton, L | 1 |
| Garcia, M | 1 |
| Harlos, M | 1 |
| Chochinov, HM | 1 |
| Szwak, K | 1 |
| Sacchetti, A | 1 |
| Kramskay, R | 1 |
| Tansky, A | 1 |
| Eisenberg, E | 1 |
| Veitsman, E | 1 |
| Baruch, Y | 1 |
| Wiebe, E | 1 |
| Podhradsky, L | 1 |
| Dijak, V | 1 |
| Kunz, M | 1 |
| Scholl, KE | 1 |
| Schu, U | 1 |
| Lautenbacher, S | 1 |
| Reid, C | 1 |
| Jerome, L | 1 |
| Park, SH | 1 |
| Bang, SM | 1 |
| Nam, E | 1 |
| Cho, EK | 1 |
| Shin, DB | 1 |
| Lee, JH | 1 |
| Ahn, JY | 1 |
| Bonomo, JB | 1 |
| Butler, AS | 1 |
| Lindsell, CJ | 1 |
| Venkat, A | 1 |
| McGowan, WA | 1 |
| Dundee, JW | 1 |
| Clarke, RS | 1 |
| Howard, PJ | 1 |
| Patterson, DR | 1 |
| Ptacek, JT | 1 |
| Carrougher, GJ | 1 |
| Sharar, SR | 1 |
| Kollarits, CR | 1 |
| Jaweed, S | 1 |
| Kollarits, FJ | 1 |
| Larson, JS | 1 |
| Lunn, JJ | 1 |
| Dunlop, TJ | 1 |
| Deen, C | 1 |
| Lind, S | 1 |
| Voyle, RJ | 1 |
| Prichard, JG | 1 |
| Nath, C | 1 |
| Saxena, RC | 1 |
| Gupta, MB | 1 |
| Spiritus, A | 1 |
| Huygens, M | 1 |
| Callebaut, F | 1 |
| Wolanskyj, AP | 1 |
| Schroeder, G | 1 |
| Wilson, PR | 1 |
| Habermann, TM | 1 |
| Inwards, DJ | 1 |
| Witzig, TE | 1 |
| Graham, CW | 1 |
| Pagano, RR | 1 |
| Conner, JT | 1 |
| Lipp, M | 1 |
| Daubländer, M | 1 |
| Milligan, DW | 1 |
| Howard, MR | 1 |
| Judd, A | 1 |
| Koike, K | 1 |
| Yokoi, A | 1 |
| Okabe, H | 1 |
| Yagi, T | 1 |
| Isomura, A | 1 |
| Miyata, Y | 1 |
| Gotoh, M | 1 |
| Sugiura, M | 1 |
| Rizzo, PA | 1 |
| Pierelli, F | 1 |
| Pozzessere, G | 1 |
| Fattapposta, F | 1 |
| Sanarelli, L | 1 |
| Morocutti, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double-blind, Randomized, Placebo-controlled Study on the Effect of Multimodal Analgesia on Pain With Insertion of Levonorgestrel-releasing Intrauterine System[NCT02799641] | 61 participants (Actual) | Interventional | 2016-07-31 | Completed | |||
| An Evaluation of Hydrocodone/Acetaminophen for Pain Control in First Trimester Surgical Abortion[NCT01330459] | Phase 4 | 121 participants (Actual) | Interventional | 2011-02-28 | Completed | ||
| Oral Sedation During Cervical Dilator Placement: A Randomized Controlled Trial[NCT03202550] | Phase 4 | 27 participants (Actual) | Interventional | 2017-06-28 | Completed | ||
| An Evaluation of the Paracervical Block for Pain Control in First Trimester Surgical Abortion[NCT01094366] | Phase 4 | 121 participants (Actual) | Interventional | 2010-04-30 | Completed | ||
| Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture[NCT00188227] | Phase 4 | 748 participants | Interventional | 2001-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To assess need for additional intraoperative and/or postoperative pain medication (NCT01330459)
Timeframe: 30 minutes after completion of the procedure (which started 45-90 minutes after study drug administration)
| Intervention | Participants (Count of Participants) |
|---|---|
| Hydrocodone/Acetaminophen | 0 |
| Placebo | 0 |
To determine whether HC/APAP, given in addition to a standard regimen of ibuprofen, lorazepam, and PCB, affects patient pain perception at the time of uterine aspiration, as measured by distance (mm) from the left of the 100 mm visual analog scale (VAS). The number 0 indicates no pain, and 100 indicates worst pain imaginable. (NCT01330459)
Timeframe: At time of uterine aspiration (baseline)
| Intervention | mm (Mean) |
|---|---|
| Hydrocodone/Acetaminophen | 65.7 |
| Placebo | 63.1 |
Distance (mm) from the left of the 100 mm VAS scale (VAS anchors: 0 = none, 100 mm = worst imaginable) recorded after cervical dilation (NCT01330459)
Timeframe: During procedure (approximately 45-90 min after hydrocodone/acetaminophen or placebo, and within 5 minutes of procedure starting)
| Intervention | mm (Mean) |
|---|---|
| Hydrocodone/Acetaminophen | 47.2 |
| Placebo | 43.9 |
To assess whether HC/APAP is associated with nausea, measured on the 100 mm VAS, recorded 30 minutes postoperatively. VAS anchors: 0 indicates no pain, and 100 indicates worst pain imaginable. (NCT01330459)
Timeframe: 30 minutes after completion of the procedure (which started 45-90 minutes after study drug administration)
| Intervention | mm (Mean) |
|---|---|
| Hydrocodone/Acetaminophen | 19.4 |
| Placebo | 11.4 |
Distance (mm) from the left of the 100 mm VAS (VAS anchors: 0 = unsatisfied, 100 mm = very satisfied) recorded 30 minutes after completion of the procedure. (NCT01330459)
Timeframe: 30 minutes after completion of the procedure (which started 45-90 minutes after study drug administration)
| Intervention | mm (Mean) |
|---|---|
| Hydrocodone/Acetaminophen | 74.8 |
| Placebo | 67.3 |
Compare pain scores on a 100 mm visual analog scale (VAS) (anchors 0=no pain; 100=worst pain ever) (NCT03202550)
Timeframe: pain score given prior to administration of study drugs, up to 1 minute
| Intervention | units on a scale (Median) |
|---|---|
| Placebo Arm | 3 |
| Active Drug Arm: Lorazepam and Oxycodone | 2 |
Compare pain scores on a 100 mm visual analog scale (VAS) (anchors 0=no pain; 100=worst pain ever) (NCT03202550)
Timeframe: Immediately after the last dilator is placed, up to 1 minute
| Intervention | units on a scale (Median) |
|---|---|
| Placebo Arm | 55 |
| Active Drug Arm: Lorazepam and Oxycodone | 44 |
Assess whether desired number of dilators was not able to be successfully inserted, comparing 2 arms. (NCT03202550)
Timeframe: After speculum removed, up to 30 minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo Arm | 13 |
| Active Drug Arm: Lorazepam and Oxycodone | 10 |
Compare pain scores on a 100 mm visual analog scale (VAS) (anchors 0=no pain; 100=worst pain ever). This was to be assessed at 15 minutes after last dilator is placed. Some participants had this assessment done up to 45 minutes after last dilator was placed because it could not be done at 15 minutes (some were being attended to by a nurse at the 15 minutes mark). (NCT03202550)
Timeframe: Assessed up to 45 minutes after last dilator placed
| Intervention | units on a scale (Median) |
|---|---|
| Placebo Arm | 29 |
| Active Drug Arm: Lorazepam and Oxycodone | 13 |
Compare pain scores on a 100 mm visual analog scale (VAS) (anchors 0=no pain; 100=worst pain ever) (NCT03202550)
Timeframe: pain score given immediately after first dilator placed, up to 1 minute
| Intervention | units on a scale (Median) |
|---|---|
| Placebo Arm | 50 |
| Active Drug Arm: Lorazepam and Oxycodone | 9 |
Compare pain scores on a 100 mm visual analog scale (VAS) (anchors 0=no pain; 100=worst pain ever) (NCT03202550)
Timeframe: pain score given at time of speculum placement, up to 1 minute
| Intervention | units on a scale (Median) |
|---|---|
| Placebo Arm | 20 |
| Active Drug Arm: Lorazepam and Oxycodone | 11 |
Compare pain scores on a 100 mm visual analog scale (VAS) (anchors 0=no pain; 100=worst pain ever) (NCT03202550)
Timeframe: Immediately scored at time of tenacula placement, up to 1 minute
| Intervention | units on a scale (Median) |
|---|---|
| Placebo Arm | 31 |
| Active Drug Arm: Lorazepam and Oxycodone | 50 |
Compare pain scores on a 100 mm visual analog scale (VAS) (anchors 0=no pain; 100=worst pain ever) (NCT03202550)
Timeframe: pain score given before specula placed, up to 1 minute
| Intervention | units on a scale (Median) |
|---|---|
| Placebo Arm | 1 |
| Active Drug Arm: Lorazepam and Oxycodone | 1 |
Compare pain scores on a 100 mm visual analog scale (VAS) (anchors 0=no pain; 100=worst pain ever) (NCT03202550)
Timeframe: pain score given at time of paracervical block administration, up to 1 minute
| Intervention | units on a scale (Median) |
|---|---|
| Placebo Arm | 57 |
| Active Drug Arm: Lorazepam and Oxycodone | 51 |
2 reviews available for lorazepam and Ache
| Article | Year |
|---|---|
Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents?
Topics: Analgesics; Animals; Benzodiazepines; Brain; GABA Agonists; GABA-A Receptor Agonists; Humans; Loraze | 2009 |
Comparing drugs for short-term sedation.
Topics: Anesthesia; Benzodiazepines; Conscious Sedation; Diazepam; Flumazenil; Humans; Lorazepam; Midazolam; | 1994 |
12 trials available for lorazepam and Ache
| Article | Year |
|---|---|
Oral administration of analgesia and anxiolysis for pain associated with bone marrow biopsy.
Topics: Acetaminophen; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics; Anesthesia, Local; | 2010 |
Prophylactic analgesia before percutaneous liver biopsy: a clinical comparative study.
Topics: Adult; Analgesia; Analgesics, Opioid; Anti-Anxiety Agents; Anxiety; Biopsy, Needle; Diazepam; Female | 2011 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
The effect of lorazepam on pain and anxiety in abortion.
Topics: Abortion, Induced; Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazep | 2003 |
GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam.
Topics: Adult; Double-Blind Method; Female; GABA Modulators; Hot Temperature; Humans; Lorazepam; Male; Neura | 2006 |
A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Biopsy, Needle; Bone Marrow; Double-Blind Method; Fema | 2008 |
Comparison of the subjective effects and plasma concentrations following oral and i.m. administration of flunitrazepam in patients.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Diazepam; Double-Blind M | 1980 |
Lorazepam as an adjunct to opioid analgesics in the treatment of burn pain.
Topics: Adult; Analgesics, Opioid; Anti-Anxiety Agents; Anxiety; Burns; Drug Therapy, Combination; Female; H | 1997 |
Use of combined oral narcotic and benzodiazepine for control of pain associated with bone marrow examination.
Topics: Administration, Oral; Adult; Analgesia; Benzodiazepines; Bone Marrow Examination; Drug Therapy, Comb | 1999 |
Topical anesthesia without intracameral lidocaine in cataract surgery.
Topics: Aged; Aged, 80 and over; Anesthetics, Local; Blepharospasm; Cataract Extraction; Humans; Hypnotics a | 2000 |
A randomized, placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Analgesics, Opioid; Anti-Anxiety Agents; Anxiety | 2000 |
Pain and clinical thrombophlebitis following intravenous diazepam and lorazepam.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Diazepam; Double-Blind Metho | 1978 |
Premedication with lorazepam before bone marrow biopsy.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Marrow Examination; Double-Blind Method; Female; Human | 1987 |
14 other studies available for lorazepam and Ache
| Article | Year |
|---|---|
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Analgesia and Sedation at Terminal Extubation: A Secondary Analysis From Death One Hour After Terminal Extubation Study Data.
Topics: Airway Extubation; Analgesia; Analgesics, Opioid; Benzodiazepines; Child; Child, Preschool; Humans; | 2023 |
Benzodiazepine abuse among athletes: Pain relief or just a weapon against insomnia? A clinical case study.
Topics: Adult; Athletes; Female; Humans; Lorazepam; Pain; Pain Management; Sleep; Sleep Initiation and Maint | 2019 |
[Indications and use of benzodiazepines in a palliative care unit].
Topics: Adult; Aged; Aged, 80 and over; Benzodiazepines; Female; Humans; Lorazepam; Male; Middle Aged; Neopl | 2008 |
The palliative medication kit: an effective way of extending care in the home for patients nearing death.
Topics: Aged; Analgesics, Opioid; Benzodiazepines; Female; Home Care Services; Humans; Hypnotics and Sedativ | 2009 |
Droperidol use in pediatric emergency department patients.
Topics: Adjuvants, Anesthesia; Adolescent; Anti-Anxiety Agents; Antiemetics; Central Nervous System Depressa | 2010 |
Medicating "Margaret".
Topics: Advance Directives; Alzheimer Disease; Analgesics, Opioid; Antipsychotic Agents; Electroconvulsive T | 2006 |
Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia.
Topics: Amitriptyline; Analgesics; Anti-Ulcer Agents; Anticoagulants; Antidepressive Agents; Anxiety; Cardio | 2007 |
Inadequate provision of postintubation anxiolysis and analgesia in the ED.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Anxiety Agents; Anxiety; Cohort Studies; Emergency Service, Ho | 2008 |
Comparison of pain, motility, and preoperative sedation in cataract phacoemulsification patients receiving peribulbar or sub-Tenon's anesthesia.
Topics: Anesthesia, Local; Anesthetics, Local; Diazepam; Eye Movements; Follow-Up Studies; Humans; Hypnotics | 1998 |
Effect of dopamine agonists and antagonists on the lorazepam withdrawal syndrome in rats.
Topics: Acoustic Stimulation; Aggression; Animals; Anti-Anxiety Agents; Dopamine Agonists; Dopamine Antagoni | 2000 |
[Premedication and analgesic dose procedures in dental medicine].
Topics: Anesthesia, Dental; Anesthesia, Local; Buprenorphine; Clorazepate Dipotassium; Diazepam; Flunitrazep | 1991 |
The suppressive effect of autogenic training against pain stimulus on oral mucosa.
Topics: Autogenic Training; Heart Rate; Humans; Injections; Lorazepam; Male; Mouth Mucosa; Pain; Pulse | 1985 |
Pain, anxiety, and contingent negative variation: a clinical and pharmacological study.
Topics: Adult; Anxiety; Contingent Negative Variation; Electrophysiology; Female; Humans; Lorazepam; Male; M | 1985 |